BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 3, 2014
View Archived Issues
Studies in animal model support idea of AAV-snRNA mediated exon-skipping for DMD
Read More
RaQualia presents preclinical findings on novel TRPM8 antagonists for neuropathic pain
Read More
Data and safety monitoring board recommends continuing phase III study of CPX-351
Read More
TG Therapeutics confirms start of trial of TGR-1202 with ibrutinib for B-cell malignancies
Read More
Ampio provides week 20 update on open-label portion of STRUT study of Ampion
Read More
Abeona Therapeutics raises funding to support Sanfilippo syndrome program
Read More
Unum Therapeutics initiates phase I trial of antibody-coupled T-cell receptor therapy
Read More
Homologous recombination deficiency score can predict response to niraparib in ovarian cancer
Read More
Lilly reports discovery and preclinical characterization of novel cathepsin S inhibitor
Read More
Nippon Shinyaku and Pfizer launch Tramal in Japan for cancer pain and chronic pain
Read More
Phase I results for recombinant ApoA-I Milano/phospholipid complex as treatment of atherosclerosis
Read More
Abivax completes first-in-human study of ABX-464
Read More
Actelion submits selexipag for approval in Europe
Read More
Eternity Bioscience patent details novel BRAF inhibitors
Read More
Dr August Wolff Group patent reports kappa-opioid agonists
Read More
N30 Pharmaceuticals presents novel CFTR modulators
Read More
Jiangsu Hengrui Medicine patents URAT1 inhibitors
Read More
Phase I data presented for CC-220 as treatment for SLE and other autoimmune diseases
Read More
Lung Therapeutics' LTI-01 receives FDA orphan drug designation
Read More
Pfizer acquires Baxter's marketed vaccines
Read More
Synageva BioPharma provides regulatory update for sebelipase alfa
Read More
Actinogen completes acquisition of Corticrine
Read More
Otsuka Pharmaceutical to acquire Avanir Pharmaceuticals
Read More
Momenta Pharmaceuticals to initiate clinical trial of M-923, a Humira biosimilar
Read More
EMA starts review of MAA of NPS Pharmaceuticals' Natpar
Read More
Cepheid receives FDA clearance to market norovirus diagnostic
Read More
FDA approves Xuanzhu Pharma's IND application for pirotinib
Read More